PHGDH

Chr 1AR

phosphoglycerate dehydrogenase

Also known as: 3-PGDH, 3PGDH, HEL-S-113, NLS, NLS1, PDG, PGAD, PGD

The enzyme catalyzes the first step of L-serine biosynthesis by oxidizing 3-phospho-D-glycerate to 3-phosphonooxypyruvate, requiring NAD/NADH as a cofactor. Biallelic mutations cause autosomal recessive phosphoglycerate dehydrogenase deficiency and Neu-Laxova syndrome 1, both presenting with severe congenital microcephaly and developmental delay. The gene shows tolerance to loss-of-function variants (LOEUF 0.778), suggesting complete loss of enzyme function may be required for disease manifestation.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismARLOEUF 0.782 OMIM phenotypes
Clinical SummaryPHGDH
🧬
Gene-Disease Validity (ClinGen)
neurometabolic disorder due to serine deficiency · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
29 unique Pathogenic / Likely Pathogenic· 78 VUS of 200 total submissions
📖
GeneReview available — PHGDH
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.78LOEUF
pLI 0.000
Z-score 2.34
OE 0.46 (0.280.78)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.21Z-score
OE missense 0.97 (0.881.06)
295 obs / 305.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.46 (0.280.78)
00.351.4
Missense OE0.97 (0.881.06)
00.61.4
Synonymous OE1.06
01.21.6
LoF obs/exp: 10 / 21.8Missense obs/exp: 295 / 305.2Syn Z: -0.57
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
moderatePHGDH-related Neu-Laxova syndromeOTHERAR
definitivePHGDH-related phosphoglycerate dehydrogenase deficiencyLOFAR

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6649th %ile
GOF
0.4777th %ile
LOF
0.3648th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

200 submitted variants in ClinVar

Classification Summary

Pathogenic13
Likely Pathogenic16
VUS78
Likely Benign81
Benign2
13
Pathogenic
16
Likely Pathogenic
78
VUS
81
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
4
2
7
0
13
Likely Pathogenic
16
0
0
0
16
VUS
0
61
11
6
78
Likely Benign
0
0
46
35
81
Benign
0
0
2
0
2
Total20636641190

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PHGDH · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →